$ 11.4 billion
Announced
17/6/2019
Kurt Stumpo - US Editor
United States
Public acquisition
M&A
United States
Pharmaceuticals and life sciences
Party: Guggenheim Securities (Financial adviser)
Party: Morgan Stanley (Financial adviser)
Lawyer: Andrew Bab
Party: Array Biopharma (Target)